JACC Asia - Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4): A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

JACC Specialty Journals - A podcast by American College of Cardiology - Tuesdays